Author:
Terao Itsuki,Honyashiki Mina,Inoue Takeshi
Subject
Neurology,Molecular Biology,Aging,Biochemistry,Biotechnology
Reference31 articles.
1. The problem of aducanumab for the treatment of Alzheimer disease;Alexander;Ann. Intern. Med.,2021
2. Alzheimer's Disease International, 2019. World Alzheimer Report 2019: attitudes to dementia. 〈https://www.alz.co.uk/research/world-report-2019〉 (accessed June 2 2022).
3. Anon{C}Higgins J.P.T., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., Welch V.A. (editors){C}. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.
4. Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease;Athar;Mol. Biol. Rep.,2021
5. Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: a systematic review and meta-analysis of phase III RCTs in Alzheimer's disease;Avgerinos;Ageing Res. Rev.,2021
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献